Prolonged oral ganciclovir (GCV) reduces the incidence of CMV infection and disease after lung transplantation (LTx) Source: Eur Respir J 2006; 28: Suppl. 50, 777s Year: 2006
Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems Year: 2009
Strict antifungal prophylaxis reduces the risk of invasive fungal infections after lung transplantation (LTx) Source: Eur Respir J 2006; 28: Suppl. 50, 777s Year: 2006
Effective prevention of human cytomegalovirus (HCMV) disease in lung transplant recipients (LTR) by pre-emptive therapy based on HCMV monitoring in blood and lung Source: International Congress 2019 – Lung transplantation: from bench to bedside Year: 2019
Basiliximab induction reduces the incidence of acute rejection in lung transplant patients Source: International Congress 2018 – Moving lung transplantation forward Year: 2018
CMV management in lung transplant recipients Source: School Course 2012 - Lung Transplantation Year: 2012
Infectious complications after lung transplantation Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=193 Year: 2003
Azathioprine discontinuation and medium and long term outcomes after lung transplantation Source: International Congress 2015 – Outcomes of lung transplantation Year: 2015
Early sirolimus immunosuppression is safe in lung transplantation Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012
Airway complications following lung transplantation: long term outcome of silicone stenting Source: Eur Respir J 2006; 28: Suppl. 50, 722s Year: 2006
Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation Source: Eur Respir J 2001; 18: Suppl. 33, 298s Year: 2001
Cytomegalovirus infection in lung transplant patients: the role of prophylaxis and recipient-donor serotype matching Source: Eur Respir J 2005; 26: Suppl. 49, 636s Year: 2005
Long-term follow-up of lung transplant recipients with obstructive airway complications Source: Annual Congress 2008 - Donor organs and complications after lung transplantation Year: 2008
Incidence of viral infections in patients with lung transplantation Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012
Diagnosis of latent tuberculosis infection in patients with chronic liver disease undergoing liver transplantation: performance of the new IFN-γ-based assays Source: Eur Respir J 2007; 30: Suppl. 51, 752s Year: 2007
Treatment options in chronic GVHD and CLAD post lung transplantation Source: International Congress 2016 – Chronic graft-versus-host disease and chronic allograft dysfunction after lung transplantation: similarities and dissimilarities Year: 2016
Has Palivizumab prophylaxis effect on long time protection cystic fibrosis children from infections? Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019
Perioperative lung transplant management Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=130 Year: 2003
Positive impact of tacrolimus-based immunosuppression after lung transplantation – an analysis of potential risk factors for long-term survival Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007